On October 11, 2013, Promega Corporation will host a grand opening celebration to unveil its new cGMP manufacturing facility, the Feynman Center, dedicated to serving customers who need molecular biology reagents for in vitro diagnostic (IVD) assays. This includes components such as sample preparation systems and reagents, which can be used in molecular diagnostic tests provided by other IVD medical device manufacturers.
Follow Evolution Global Talent Attraction on Twitter, Facebook and LinkedIN to keep up-to-date with news and trends from the biotechnology, biosciences, medical device, IT and Intellectual Property industries.